Symbol
| PDGFB
| contributors: mct/ - updated : 05-11-2017
|
HGNC name
| platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)
|
HGNC id
| 8800
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| translocation
| --other
| protein chimeric
|
translocation t(17;22) (q22;q13) with chimeric proteins 5' - COL1A1 - PDGFB - 3' in meningiomas, in dermatofibrosarcoma protuberans | constitutional
|  
|  
| --low
|  
|
in human venous malformations (VM) lesions | constitutional
|  
|  
|  
| loss of function
|
increases hepatic vascular permeability and enhances insulin sensitivity | tumoral
|  
|  
| --over
|  
|
with LAMTOR5 were highly expressed in breast cancer cell lines | |
Susceptibility
|
meningiomas dermatofibrosarcoma protuberans |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
digestive | liver | | |
anti-platelet therapy or selective inhibition of PDGFB might reduce biliary fibrosis in patients with liver disease |
| | | |
| transgenic mice in which Pdgf-B was over-expressed, exhibited enhanced apoptosis in the developing corpus striatum, and in retinal progenitors results in abnormal retinal vessel formation |